United States · FDA National Drug Code directory
BUMETANIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70748-323_39d376d9-2fab-40d3-8592-668c5083a0c9
- Product NDC
- 70748-323
- Form
- INJECTION
- Composition / generic term
- Bumetanide
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241111
- Source listing expiry
- 20261231
Source-listed ingredients
- BUMETANIDE — .25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (70748-323-10) / 4 mL in 1 VIAL · 70748-323-10
- 10 VIAL in 1 CARTON (70748-323-11) / 10 mL in 1 VIAL · 70748-323-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →